Cargando…
Expert Evaluation of Strategies to Modernize Newborn Screening in the United States
IMPORTANCE: Novel therapies, including cell and gene therapies, can radically improve outcomes among patients with rare disorders, especially if provided early. Newborn screening (NBS) could support early access to novel therapies, but the speed of new therapy development is a disruptive event for w...
Autores principales: | Bailey, Donald B., Porter, Katherine Ackerman, Andrews, Sara M., Raspa, Melissa, Gwaltney, Angela Y., Peay, Holly L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717100/ https://www.ncbi.nlm.nih.gov/pubmed/34964853 http://dx.doi.org/10.1001/jamanetworkopen.2021.40998 |
Ejemplares similares
-
Preparing newborn screening for the future: a collaborative stakeholder engagement exploring challenges and opportunities to modernizing the newborn screening system
por: Andrews, Sara M., et al.
Publicado: (2022) -
Information and Emotional Support Needs of Families Whose Infant Was Diagnosed With SCID Through Newborn Screening
por: Raspa, Melissa, et al.
Publicado: (2020) -
Education and Consent for Population-Based DNA Screening: A Mixed-Methods Evaluation of the Early Check Newborn Screening Pilot Study
por: Peay, Holly L., et al.
Publicado: (2022) -
Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening
por: Raspa, Melissa, et al.
Publicado: (2023) -
Early Check: translational science at the intersection of public health and newborn screening
por: Bailey, Donald B., et al.
Publicado: (2019)